APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,408 | +336.9% | 115,889 | +945.6% | 0.01% | +500.0% |
| Q2 2023 | $1,009 | -56.7% | 11,084 | -68.6% | 0.00% | -66.7% |
| Q1 2023 | $2,328 | -46.9% | 35,304 | -58.4% | 0.00% | -50.0% |
| Q4 2022 | $4,386 | -99.9% | 84,820 | +84.0% | 0.01% | +20.0% |
| Q3 2022 | $3,148,000 | +478.7% | 46,096 | +282.8% | 0.01% | +400.0% |
| Q2 2022 | $544,000 | +300.0% | 12,043 | +348.9% | 0.00% | – |
| Q1 2022 | $136,000 | +240.0% | 2,683 | +117.1% | 0.00% | – |
| Q3 2021 | $40,000 | -28.6% | 1,236 | -6.6% | 0.00% | – |
| Q1 2021 | $56,000 | -92.6% | 1,324 | -90.0% | 0.00% | -100.0% |
| Q4 2020 | $754,000 | -40.5% | 13,189 | -75.0% | 0.00% | -50.0% |
| Q3 2019 | $1,268,000 | – | 52,655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |